A Blog by AMCP CEO Susan Cantrell

AMCP_Beyond 


 

 

As the ACA's Future Remains in Limbo, PIE Legislation Moves Steadily Forward

 
 Leg-reg blog 2 
September 28, 2017

Health care reform historically has been one of the most contentious issues on Capitol Hill. The current fight to repeal the Affordable Care Act (ACA) is just the latest in a string of battles that reaches back many decades, including to the founding of Medicare and Medicaid.

But not every major health care policy change generates as much heat as the ACA or Medicaid. The Academy is cautiously optimistic about the future of an important bill that would allow for more sharing of information on pharmaceuticals moving through the development pipeline.

That bill, as you probably know, is the “Pharmaceutical Information Exchange (PIE) Act of 2017” (H.R. 2026). Sponsored by Rep. Brett Guthrie (R-KY), H.R. 2026 would allow manufacturers to proactively share certain clinical and economic information with decision makers on medicines in advance of FDA approval. Even though FDA draft guidance in January 2017 included an allowance for PIE, a more permanent solution is necessary to ensure correct procedures are incorporated into law.

AMCP has been the prime advocate for the PIE Act, and has worked with Guthrie’s staff to advance the bill through Congress, including by finding bipartisan sponsors.

I’m happy to say we made progress in this aim during AMCP’s recent Legislative Days on Capitol Hill. AMCP members and staff targeted nearly 30 undecided Representatives who had expressed an initial interest in supporting H.R. 2026. These lawmakers also hold key positions on the House Energy and Commerce Committee, and the Senate Health, Education, Labor and Pensions Committee, where this bill will emerge.

From these multiple meetings, common themes emerged: none of the lawmakers and aides expressed outright opposition to the bill, and in fact, they all showed an appreciation for our position. They also praised us for our ability to clearly explain the value of this initiative in nonpartisan way. And they left the door open for more discussion and eventual support. I am proud of our member and staff outreach, and their ability to cross ideological divides and appeal to commonsense solutions.

While we still have much work to do to cross the finish line, I can say we are making steady progress to build support among both Democrats and Republicans. This is how the legislative process should work.

 
   

AMCP Offers Prayers, Collects Items for Victims of Hurricane Harvey; Will Deliver Portion of Socks Collected by AMCP Foundation to Houston Charities

 
  
September 5, 2017

Like everyone across the country, AMCP members and staff share a deep concern for the safety and wellbeing of thousands of people displaced by Hurricane Harvey. Read More.
 
   

NEJM Article on ‘Accelerated Approvals and Expensive Drugs’ Misses Promising Solution 

 

August 21, 2017  

A recent article in The New England Journal of Medicine (NEJM) caught my attention for a couple of reasons. Read More

   

Leading on Today’s Most Pressing Challenges: AMCP Partnership Forum Develops Action Plan for Advancing Value-Based Contracting

 
 

June 29, 2017 

One of the many things that I’m proud of at AMCP is our role as a convener. We bring together several times a year key stakeholders representing a diverse range of positions to address common health care challenges. Read More. 

 
 


My Recent "Field Trip" to Arizona Highlights AMCP's Breadth and Depth

 
 

May 31, 2017 

One maxim I hold dear is the value of getting out of the office now and then to see how things are working in the field. I had that opportunity recently with a “field trip” to the beautiful state of Arizona, where I participated in several events: a workshop on strategies to strengthen association governance, a conference on integrating data in pharmacy practice, a visit with student pharmacists, and a tour of an innovative MTM service center. ... Read more

 
 


AMCP Nexus 2017 Theme Announced: “Changing the Way We Pay for Health Care”

 
 

May 2, 2017 

Volume to value, quantity to quality: such transitions in health care today are like a rock tossed in a pond. The ripple effects are far-reaching and unstoppable. So important is this transformation that we’re dedicating a significant amount of programming to the topic at our fall conference in Dallas (Oct. 16-19). In fact, we’re calling it “AMCP Nexus 2017: Changing the Way We Pay for Health Care.” ... Read more.

 
 


Eye on the Hill: AMCP Sees Progress in PIE Bill and Will Continue to Promote Comprehensive Pharmacy Benefit in Health Care Reform Efforts

 
 

April 11, 2017 

Whoever said, “May you live in interesting times,” could have been talking about Congressional health care policy debates circa 2017. Never a dull moment!

Many things are happening on the health care legislative front, and AMCP has been in the thick of it. ... Read more.

 
 


AMCP Celebrates Early Win: FDA Issues Draft Guidance to Improve Communications Between Biopharmaceutical Companies and Population Health Decision Makers

 
 

March 1, 2017 

Every morning — like many of you — I settle behind my desk, take a sip of coffee and read the AMCP Daily Dose. This publication, full of valuable news and information, frequently highlights issues and individuals we’re featuring at our Annual Meeting, March 27-30, in Denver. Several caught my eye recently. ... Read more.

 
 


AMCP Celebrates Early Win: FDA Issues Draft Guidance to Improve Communications Between Biopharmaceutical Companies and Population Health Decision Makers

 
 

February 1, 2017 

Sometimes the best laid plans are upended when you least expect it!

In mid-January, the FDA released draft guidance to facilitate the sharing of information between biopharmaceutical companies and population health decision makers. To say we were pleasantly surprised is an understatement. ... Read more.

 
 


Making PIE to Better Serve Patients

 
 

January 11, 2017 

Let’s imagine you’re a big city mayor and it’s time to order a new fleet of police cars for next year. Applying due diligence, you set out to compare various models from a variety of manufacturers. ... Read more.

 
 


Century Cures Act Advances AMCP's FDAMA Goals, Improves Value-Based Communications Between Manufacturers and Managed Care Pharmacy

 
 

December 22, 2016 

Who says Congress can’t get anything done…and with bipartisan support to boot? With impressive speed and purpose, the House and Senate overwhelmingly passed the 21st Century Cures Act in the waning days of the 114th Congress, followed by President Obama’s prompt signature. ... Read more.

 
 


Pharmacy Profession Comes Together to Help Document and Improve Patient Outcomes Through Medication Therapy Management

 
 

November 7, 2016 

People can accomplish remarkable things when they work toward a common goal. That’s what happened recently when a diverse group of pharmacy stakeholders gathered to develop standardized terms for medication therapy management (MTM) services. ... Read more.

 
 


AMCP really knows how to get things done!

 
 

October 13, 2016 

Not long ago a respected individual in the health care arena told one of my senior staff: “Compared to other associations I work with, AMCP really knows how to get things done.” You cannot imagine how proud I felt ... Read more.

 
 


AMCP Volunteers Are a Happy Lot

 
 

September 20, 2016 

There are many ways to measure the health and vitality of a professional association. The most crucial indicators, I’ve found, center on the engagement of an organization’s volunteers. This can be measured in the number of volunteer opportunities provided, the number of members who sign up, and the level of satisfaction they get from volunteering. ... Read more.

 
 


The Post Cites Pharmacists’ Expanding Role on Medical Teams

 
 

August 26, 2016 

Last week I saw a headline that jumped off the page: “America’s other drug problem: Giving the elderly too many prescriptions” (Washington Post, Aug. 15). I couldn’t read it fast enough and encourage members to do likewise, as it highlights two of the most important developments in health care. ... Read more.

 
 


Seizing Opportunity: AMCP Nexus 2016 Offers Knowledge, Advancement and More

 
 

August 3, 2016 

“Healing is a matter of time, but it is sometimes also a matter of opportunity,” said the great Hippocrates, father of western medicine.

Opportunity, in fact, is a crucial element in the work that managed care pharmacy professionals engage in every day to improve the health, wellbeing and “healing” of millions of patients. We seize opportunities to find the right medicines for the right patients at the right time. ... Read more.

 
 


BRC Now Lets You Look It Up

 
 

July 13, 2016 

It was only ten years ago when biosimilars were so new that the New York Times described them as “so-called.” As late as five years ago newspapers put quotation marks around the term, as in “biosimilars.” At the time some still called them “follow-on” biopharmaceutics. ... Read more.

 
 


Is FDAMA Section 114 Finally Ready for Prime Time?

 
 

June 24, 2016 

Information is the life blood of managed care pharmacy. Of the “competent and reliable scientific” variety, that is.

Our profession operates best when we have broad access to the latest evidence-based data on the multitude of products coming to market today. We can plan, we can assess. With this information, managed care pharmacy professionals can help health care providers and patients select the right drug for the right patient at the right time, while making appropriate use of our scarce health care dollars. ... Read more.

 
 


Getting it straight with the updated AMCP Format!

 
 

May 19, 2016 

Using the best evidence possible to make informed health care decisions is a hallmark of managed care pharmacy. But making sense of the data often is no easy task, especially when it comes to analyzing pharmaceuticals and the value they bring to patients and the health care system... Read more.

 
 


CEO Susan Cantrell Addresses AMCP Annual Meeting

 
 

May 10, 2016 

New&Views announces a new monthly column by CEO Susan A. Cantrell, RPh, CAE, on breaking news and critical issues. Her first column presents her recent address―her first to the membership―at AMCP’s recent Annual Meeting.

“It is truly an honor to be standing before you today as the Academy’s new CEO. While new to the AMCP staff, I’ve been an observer and at times a participant in the terrific work of this organization. ..." Read more.